ISSN:

Journal Home

Molecular Cancer Q1 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Cancer is a journal indexed in SJR in Molecular Medicine and Oncology with an H index of 222. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 3890 €. The scope of the journal is focused on oncology, tumour biology, cancer antigens. It has an SJR impact factor of 9,263 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 9,263.

Molecular Cancer focuses its scope in these topics and keywords: expression, colon, cells, prostate, cell, cancer, association, suppresses, methylation, proliferation, ...

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Molecular Medicine (Q1) Oncology (Q1)

Price

3890 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

9,263

SJR Impact factor

222

H Index

276

Total Docs (Last Year)

558

Total Docs (3 years)

28148

Total Refs

16613

Total Cites (3 years)

465

Citable Docs (3 years)

30.3

Cites/Doc (2 years)

101.99

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Stem Cell Q1
Pharmacological Reviews Q1
Genome Medicine Q1
Journal for ImmunoTherapy of Cancer Q1
Molecular Therapy Q1

Compare this journals